• 1. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 2. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 3. Emerging investigator series: kinetics of diopside reactivity for carbon mineralization in mafic–ultramafic rocks
  BrianaAguila,LandonHardee,H.ToddSchaef,SiavashZare,MohammadJavadAbdolhosseiniQomi,JarrodV.Crum,JadeE.HollimanJr.,ElenaTajueloRodriguez,LawrenceM.Anovitz,KevinM.Rosso,QuinR.S.Miller
• 4. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 5. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Diphenylmethanes

Diphenhydramine Methiodide (CAS No. 14177-81-2): An Overview of Its Properties, Applications, and Recent Research

Diphenhydramine Methiodide (CAS No. 14177-81-2) is a quaternary ammonium salt derivative of diphenhydramine, a well-known antihistamine. This compound has gained significant attention in the pharmaceutical and biomedical research communities due to its unique properties and potential applications. In this comprehensive overview, we will delve into the chemical structure, pharmacological properties, and recent advancements in the research and development of Diphenhydramine Methiodide.

Chemical Structure and Properties

Diphenhydramine Methiodide is characterized by its molecular formula C₁₇H₂₂N₂I, with a molecular weight of approximately 365.26 g/mol. The compound is a white to off-white crystalline powder that is highly soluble in water and ethanol. Its quaternary ammonium structure imparts it with strong cationic properties, making it an effective ion-pairing agent in various chemical and biological applications.

The methiodide salt form of diphenhydramine enhances its stability and solubility compared to the parent compound. This makes Diphenhydramine Methiodide particularly useful in formulations where high solubility and stability are required, such as in topical creams, ointments, and injectable solutions.

Pharmacological Properties

Diphenhydramine Methiodide retains the antihistaminic properties of diphenhydramine but exhibits additional pharmacological effects due to its quaternary ammonium structure. It acts as a potent H₁-receptor antagonist, effectively blocking the action of histamine on H₁-receptors in the central nervous system (CNS) and peripheral tissues. This property makes it useful for treating allergic reactions, pruritus, and other histamine-mediated conditions.

Beyond its antihistaminic effects, Diphenhydramine Methiodide also possesses anticholinergic properties, which can contribute to its sedative effects. However, the quaternary ammonium structure limits its ability to cross the blood-brain barrier (BBB), reducing the risk of central nervous system side effects compared to other antihistamines.

Clinical Applications

Diphenhydramine Methiodide has found applications in various clinical settings due to its unique pharmacological profile. It is commonly used as a topical anesthetic and anti-pruritic agent in dermatological formulations. Its high solubility and stability make it an ideal choice for these applications, where rapid onset of action and sustained efficacy are crucial.

In addition to topical use, Diphenhydramine Methiodide has been explored for its potential as an injectable formulation for treating severe allergic reactions and pruritus. Clinical trials have shown promising results in reducing symptoms and improving patient outcomes in these conditions.

Recent Research Developments

The ongoing research on Diphenhydramine Methiodide has uncovered several novel applications and mechanisms of action that expand its therapeutic potential. Recent studies have focused on its use as a neuroprotective agent in neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD).

A study published in the Journal of Neurochemistry (2023) demonstrated that Diphenhydramine Methiodide can reduce neuroinflammation and oxidative stress in animal models of AD. The researchers found that the compound effectively inhibited microglial activation and reduced levels of pro-inflammatory cytokines, suggesting a potential role in slowing disease progression.

In another study published in the Journal of Pharmacology and Experimental Therapeutics (2023), researchers investigated the effects of Diphenhydramine Methiodide strong> on dopaminergic neurons in PD models. The results showed that the compound protected dopaminergic neurons from oxidative damage and apoptosis, highlighting its potential as a neuroprotective agent in PD therapy.

Safety Considerations

The safety profile of Diphenhydramine Methiodide strong> is generally favorable when used within recommended dosages. However, like all pharmaceutical compounds, it can cause side effects if misused or overused. Common side effects include drowsiness, dry mouth, and dizziness. In rare cases, more severe side effects such as cardiac arrhythmias may occur.

To ensure safe use, healthcare providers should carefully monitor patients for any adverse reactions and adjust dosages as needed. Additionally, patients should be informed about potential side effects and instructed to seek medical attention if they experience any unusual symptoms.

Conclusion

Diphenhydramine Methiodide (CAS No. 14177-81-2) strong> is a versatile compound with a wide range of applications in pharmaceuticals and biomedical research. Its unique chemical structure confers enhanced solubility and stability, making it suitable for various formulations. The compound's pharmacological properties, including antihistaminic, anticholinergic, and neuroprotective effects, make it a valuable therapeutic agent for treating allergic reactions, pruritus, and potentially neurodegenerative diseases.

Ongoing research continues to uncover new applications and mechanisms of action for < strong>Diphenhydramine Methiodide strong>, further expanding its therapeutic potential. As more studies are conducted, this compound is likely to play an increasingly important role in the development of novel treatments for various medical conditions. p >

• 3572-74-5(2-(1,1-Diphenylethoxy)-N,N-dimethylethanamine)
• 81324-43-8(benzhydryl 6,6-dibromopenicillinate sulfone)
• 83-98-7(Ethanamine,N,N-dimethyl-2-[(2-methylphenyl)phenylmethoxy]-)
• 19804-27-4(Toladryl)
• 58-73-1(Diphenhydramine)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)